Assessing the Impact of Improvements in PASI and Itch Scores on Patients’ Quality of Life in the Treatment of Psoriasis

Abstract

Abstract is missing (Short communication)

Keywords

• Ixekizumab: quality-of-life
• moderate-to-severe psoriasis
• Itch
• PASI
• DLQI